Study identification

EU PAS number

EUPAS1000000133

Study ID

1000000133

Official title and acronym

Association between use of direct oral anticoagulants (DOACs) and increased risk of interstitial lung disease

DARWIN EU® study

No

Study countries

Germany
Italy
Spain
United Kingdom

Study description

New user active comparator cohort study examining the association between direct oral anticoagulant (DOAC) use and incidence of ILD compared to users of vitamin K antagonists among people with atrial fibrillation and venous thromboembolism.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Daniel Morales

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
EMA

More details on funding

EMA in house resources
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable